Literature DB >> 19733962

Prevalence of Parkinson's disease in Northern Jordan.

Ali Alrefai1, Majed Habahbih, Mohammad Alkhawajah, Mohammad Darwish, Waleed Batayha, Yousef Khader, Khalid El-Salem.   

Abstract

BACKGROUND: The prevalence of Parkinson's disease (PD) in Jordan is not known. This study describes the prevalence and clinical characteristics of PD in Northern Jordan.
METHODS: Patients with the diagnosis of PD seen at neurology clinics in three major hospitals in Northern Jordan during the period of March 2007 to April 2008 were enrolled. PD diagnosis was established using predefined clinical diagnostic criteria.
RESULTS: A total of 102 patients were included in the analysis (64 males; 63%, 38 females 37%). The mean age (SD) of patients was 63.3 (10.1) years and the mean age for onset of symptoms (SD) was 59.5 (12.1) years. The crude prevalence rate of PD was estimated to be 59/100,000. Clinical presentations of PD at onset of disease included; rest tremor (79.2%), bradykinesia (28.7%), rigidity (6.9%), gait problem (5%), and postural instability (2%). Eleven patients (10.9%) had a family history of PD. There was no association between the age of symptom onset, the presence of tremor, bradykinesia, or rigidity at onset, with stage of PD measured by Hoehn and Yahr scale.
CONCLUSION: PD is a moderately prevalent disease in Jordan. The clinical characteristics of PD patients are similar to those reported in other countries.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19733962     DOI: 10.1016/j.clineuro.2009.08.010

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  3 in total

1.  Medium-to-high prevalence of screening-detected parkinsonism in the urban area of Tehran, Iran: data from a community-based door-to-door study.

Authors:  Seyed-Mohammad Fereshtehnejad; Mahdiyeh Shafieesabet; Arash Rahmani; Ahmad Delbari; Johan Lökk
Journal:  Neuropsychiatr Dis Treat       Date:  2015-02-05       Impact factor: 2.570

2.  First Two-Year Observational Exploratory Real Life Clinical Phenotyping, and Societal Impact Study of Parkinson's Disease in Emiratis and Expatriate Population of United Arab Emirates 2019-2021: The EmPark Study.

Authors:  Vinod Metta; Huzaifa Ibrahim; Tom Loney; Hani T S Benamer; Ali Alhawai; Dananir Almuhairi; Abdulla Al Shamsi; Sneha Mohan; Kislyn Rodriguez; Judith Mohan; Margaret O'Sullivan; Neha Muralidharan; Sheikha Al Mazrooei; Khadeeja Dar Mousa; Guy Chung-Faye; Rukmini Mrudula; Cristian Falup-Pecurariu; Carmen Rodriguez Bilazquez; Maryam Matar; Rupam Borgohain; K Ray Chaudhuri
Journal:  J Pers Med       Date:  2022-08-09

3.  Sleep Quality, Depression, and Quality of Life After Bilateral Anodal Transcranial Direct Current Stimulation in Patients with Parkinson's Disease.

Authors:  Hikmat Hadoush; Alham Al-Sharman; Hanan Khalil; Saleem A Banihani; Muhammed Al-Jarrah
Journal:  Med Sci Monit Basic Res       Date:  2018-11-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.